What You Need To Know About Psoriasis Treatment

by Robert

Psoriasis is a chronic skin condition in which the immune system accelerates skin cell production, creating raised, scaly patches across the body. Systemic therapies treat the body as a whole, and they are a core part of care for moderate to severe cases. A specialist may also prescribe cyclosporine and biological injectables as psoriasis treatment options. Here’s more information about this condition and how to address it:

Understanding Systemic Therapy

Systemic therapies target the internal processes that drive psoriasis, making them distinct from surface-level treatments. Providers may recommend this approach when psoriasis covers a significant area of the body, or when other methods have not produced adequate results. A person’s overall health, medical history, and psoriasis type all factor into the selection process, and providers adjust treatment plans over time based on a patient’s progress. Because these medications affect the whole body, providers may schedule regular follow-up visits throughout psoriasis treatment. Blood tests and other screenings help track how the body responds.

Examining Cyclosporine

Cyclosporine is a medication that suppresses specific immune system activity. It targets pathways that contribute to rapid skin cell turnover, which is a key driver of psoriatic plaques. Providers may recommend it for adults with severe psoriasis who need a timely reduction in symptoms. They typically prescribe cyclosporine for short-term use, and they monitor patients closely throughout.

This medication strains the kidneys and may affect blood pressure, so regular testing is key. Providers review kidney function and blood pressure at each scheduled visit, adjusting the dosage or discontinuing use as needed. Cyclosporine also interacts with several other drugs. Bringing a complete list of current medications and supplements to every appointment is helpful, since your provider uses that information to assess whether cyclosporine fits your specific situation.

Exploring Biological Injectables

Biologics are derived from living cells, and they identify and block specific proteins in the immune system that directly drive psoriasis. Key targeted proteins include TNF-alpha, IL-17, IL-23, and IL-12/23, depending on the medication selected. This approach distinguishes biologics from broader systemic options like cyclosporine. Most may be administered as subcutaneous injections, delivered just beneath the skin. Some patients learn to self-administer at home after receiving instruction from a provider or clinical staff. 

Dosing schedules vary by medication type and may include:

  • TNF-alpha inhibitors: Examples include adalimumab and etanercept. Dosing varies by medication; adalimumab is generally given every other week after an initial dose, while etanercept may be given twice weekly initially and then weekly.
  • IL-17 inhibitors: Examples include secukinumab and ixekizumab. Both have initial loading schedules, followed generally by maintenance doses every four weeks.
  • IL-23 inhibitors: Examples include guselkumab and risankizumab. After initial doses, guselkumab is generally given every eight weeks and risankizumab every twelve weeks.
  • IL-12/23 inhibitors: Ustekinumab is generally given at weeks 0 and 4, followed by a dose every twelve weeks.

Before starting a biologic, providers typically order baseline screening tests, and ongoing monitoring continues throughout treatment. Providers may also review a patient’s history of infections or other conditions that affect eligibility.

Explore Psoriasis Treatment Options

Psoriasis causes chronic inflammation and skin cell buildup that sometimes affects comfort and quality of life. Cyclosporine and biological injectables provide distinct ways to treat moderate to severe psoriasis, and both require consistent medical oversight. To make the most of your next appointment, write down your questions in advance and bring a complete list of your current medications. Consult a specialist today and ask them about screening requirements and monitoring plans for this condition.

You may also like